Security Name | Ticker | % of Net Assets |
---|---|---|
ELI LILLY & COMPANY | LLY | 4.00% |
UNITEDHEALTH GROUP INC. | UNH | 3.50% |
MERCK & COMPANY, INC. | MRK | 2.94% |
JOHNSON & JOHNSON | JNJ | 2.94% |
ABBVIE INC | ABBV | 2.52% |
THERMO FISHER SCIENTIFIC | TMO | 2.31% |
AMGEN INC. | AMGN | 2.22% |
PFIZER INC | PFE | 2.05% |
DANAHER CORPORATION | DHR | 2.05% |
ABBOTT LABORATORIES | ABT | 1.97% |
ELEVANCE HEALTH INC | ANTM | 1.84% |
INTUITIVE SURGICAL, INC. | ISRG | 1.80% |
BOSTON SCIENTIFIC CORP | BSX | 1.72% |
VERTEX PHARMACEUTICALS | VRTX | 1.66% |
THE CIGNA GROUP | CI | 1.62% |
STRYKER CORP | SYK | 1.62% |
REGENERON PHARMACEUTICALS | REGN | 1.61% |
ASTRAZENECA PLC ADR | AZN | 1.54% |
MCKESSON CORPORATION | MCK | 1.38% |
BRISTOL MYERS SQUIBB CO | BMY | 1.38% |
GILEAD SCIENCES, INC. | GILD | 1.33% |
BECTON DICKINSON & CO | BDX | 1.30% |
ZOETIS INC | ZTS | 1.28% |
MEDTRONIC PLC | MDT | 1.24% |
HCA HEALTCARE INC | HCA | 1.24% |
CVS HEALTH CORP. | CVS | 1.15% |
MODERNA INC | MRNA | 1.12% |
EDWARDS LIFESCIENCES CORP | EW | 1.09% |
DEXCOM INC | DXCM | 1.09% |
AGILENT TECHNOLOGIES, INC | A | 1.01% |
CENTENE CORP | CNC | 1.00% |
HUMANA, INC. | HUM | 0.99% |
NOVO-NORDISK A/S -ADR | NVO | 0.98% |
CENCORA INC | ABC | 0.96% |
TEVA PHARMACEUTICAL | TEVA | 0.96% |
IDEXX LABORATORIES INC | IDXX | 0.95% |
IQVIA HOLDINGS INC | IQV | 0.94% |
ICON PLC | ICLR | 0.93% |
RESMED INC | RMD | 0.92% |
BIOGEN IDEC, INC. | BIIB | 0.91% |
GSK PLC-SPON ADR | GSK-W | 0.88% |
GE HEALTHCARE TECHNOLOGY | GEHC | 0.87% |
ARGENX SE - ADR | ARGX | 0.86% |
NOVARTIS ADR | NVS | 0.84% |
WEST PHARMACEUTICAL SERVI | WST | 0.82% |
VEEVA SYSTEMS-A | VEEV | 0.81% |
ZIMMER BIOMET HOLDINGS IN | ZBH | 0.77% |
ALKERMES PLC | ALKS | 0.73% |
CARDINAL HEALTH, INC. | CAH | 0.72% |
ALNYLAM PHARMACEUTICALS | ALNY | 0.69% |
WATERS CORPORATION | WAT | 0.68% |
MOLINA HEALTHCARE INC | MOH | 0.67% |
ALIGN TECHNOLOGY | ALGN | 0.66% |
HOLOGIC, INC. | HOLX | 0.66% |
COOPER COS INC/THE | COO | 0.66% |
METTLER-TOLEDO INTERNATIO | MTD | 0.65% |
QUEST DIAGNOSTICS, INC. | DGX | 0.64% |
LABORATORY CORP OF AMERIC | LH | 0.64% |
AVANTOR INC | AVTR | 0.64% |
TENET HEALTHCARE CORP | THC | 0.63% |
BAXTER INTERNATIONAL | BAX | 0.61% |
BIOMARIN PHARMACEUTICAL | BMRN | 0.61% |
ILLUMINA INC | ILMN | 0.60% |
NEUROCRINE BIOSCIENCES IN | NBIX | 0.59% |
CRISPR THERAPEUTICS AG | CRSP | 0.59% |
SHOCKWAVE MEDICAL INC | SWAV | 0.58% |
UNITED THERAPEUTICS CORP | UTHR | 0.58% |
ROYALTY PHARMA PLC- CL A | RPRX | 0.58% |
SAREPTA THERAPEU | SRPT | 0.57% |
BIO-TECHNE CORP | TECH | 0.56% |
VIATRIS INC | VTRS | 0.55% |
INSULET CORP | PODD | 0.54% |
UNIVERSAL HEALTH SERVICES | UHS | 0.53% |
NATERA INC | NTRA | 0.53% |
CATALENT INC | CTLT | 0.49% |
INCYTE CORP | INCY | 0.48% |
HENRY SCHEIN, INC. | HSIC | 0.48% |
EXACT SCIENCES | EXAS | 0.45% |
REPLIGEN CORP | RGEN | 0.42% |
REVOLUTION MEDICINES INC | RVMD | 0.41% |
BLUEPRINT MEDICI | BPMC | 0.41% |
DAVITA, INC | DVA | 0.41% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 0.41% |
CYTOKINETICS INC | CYTK | 0.40% |
MEDPACE HOLDINGS | MEDP | 0.40% |
LANTHEUS HOLDING | LNTH | 0.40% |
PENUMBRA INC | PEN | 0.40% |
HEALTHEQUITY INC | HQY | 0.40% |
EXELIXIS, INC. | EXEL | 0.39% |
HALOZYME THERAPEUTICS INC | HALO | 0.38% |
INTRA-CELLULAR T | ITCI | 0.38% |
MASIMO CORP | MASI | 0.38% |
BRUKER CORP | BRKR | 0.37% |
ACADIA HEALTHCAR | ACHC | 0.37% |
ROIVANT SCIENCES LTD | ROIV | 0.36% |
DENTSPLY SIRONA, NC. | XRAY | 0.35% |
OPTION CARE HEALTH INC | OPCH | 0.35% |
IONIS PHARMACEUTICALS, IN | IONS | 0.33% |
BRIDGEBIO PHARMA INC | BBIO | 0.31% |
INSPIRE MEDICAL SYSTEMS I | INSP | 0.30% |
APELLIS PHARMACE | APLS | 0.27% |
AXSOME THERAPEUT | AXSM | 0.27% |
ULTRAGENYX PHARM | RARE | 0.25% |
ARROWHEAD PHARMACEUTICALS | ARWR | 0.24% |
TG THERAPEUTICS | TGTX | 0.24% |
AZENTA INC | BRKS | 0.23% |
GUARDANT HEALTH INC | GH | 0.23% |
INARI MEDICAL INC | NARI | 0.23% |
R1 RCM INC | RCM | 0.20% |
TELADOC HEALTH INC | TDOC | 0.20% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.17% |
MADRIGAL PHARMAC | MDGL | 0.13% |
Other (Cash, derivatives and other liabilities) | 0.51% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC.
© 2024 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.